• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛伐他汀治疗对家族性高胆固醇血症患者低密度脂蛋白亚组分分布及组成的影响。

The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia.

作者信息

de Graaf J, Demacker P N, Stalenhoef A F

机构信息

Department of General Internal Medicine, University Hospital, Nijmegen, Netherlands.

出版信息

Neth J Med. 1993 Dec;43(5-6):254-61.

PMID:8107933
Abstract

The effect of simvastatin treatment on the low-density lipoprotein (LDL) subfraction profile was studied in 26 patients with familial hypercholesterolaemia. Before treatment LDL consisted of three LDL subfractions, using density-gradient ultracentrifugation (LDL1, LDL2 and LDL3) present in a relatively narrow density range (d = 1.030-1.045 g/ml). Simvastatin did not influence this profile with respect to the number and density range of the LDL subfractions. However, the composition of the isolated LDL subfractions changed after treatment, as evidenced by the reversal towards normal of the increased cholesterol/protein ratio (mean 1.51 before vs. 1.38 after therapy, p < 0.01; mean 1.36 in normolipidaemic subjects). When the subjects were stratified by their plasma triglyceride levels or the change in plasma triglycerides during simvastatin therapy, a strong dependence of the LDL subfraction profile and its composition on plasma triglyceride levels was observed; increasing plasma triglyceride levels were associated with a more dense LDL subfraction profile, characterized by a high relative contribution of dense LDL3 to total LDL and changes in LDL composition, reflected by a relatively low cholesterol/protein ratio. Our results indicate that in patients with familial hypercholesterolaemia: (1) plasma triglyceride levels have an important role in determining the properties of LDL and (2) simvastatin treatment results in changes in composition of LDL, which may affect the intrinsic metabolic characteristics and thus the atherogenic potential of LDL.

摘要

在26例家族性高胆固醇血症患者中研究了辛伐他汀治疗对低密度脂蛋白(LDL)亚组分谱的影响。治疗前,采用密度梯度超速离心法,LDL由三个LDL亚组分组成(LDL1、LDL2和LDL3),存在于相对较窄的密度范围内(d = 1.030 - 1.045 g/ml)。辛伐他汀对LDL亚组分的数量和密度范围未产生影响。然而,治疗后分离出的LDL亚组分的组成发生了变化,胆固醇/蛋白质比值升高趋势逆转至正常即为明证(治疗前平均为1.51,治疗后为1.38,p < 0.01;正常血脂受试者平均为1.36)。当根据受试者的血浆甘油三酯水平或辛伐他汀治疗期间血浆甘油三酯的变化进行分层时,观察到LDL亚组分谱及其组成强烈依赖于血浆甘油三酯水平;血浆甘油三酯水平升高与更致密的LDL亚组分谱相关,其特征为致密的LDL3对总LDL的相对贡献较高以及LDL组成的变化,表现为胆固醇/蛋白质比值相对较低。我们的结果表明,在家族性高胆固醇血症患者中:(1)血浆甘油三酯水平在决定LDL的性质方面起重要作用;(2)辛伐他汀治疗导致LDL组成发生变化,这可能会影响LDL的内在代谢特征,进而影响其致动脉粥样硬化潜力。

相似文献

1
The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia.辛伐他汀治疗对家族性高胆固醇血症患者低密度脂蛋白亚组分分布及组成的影响。
Neth J Med. 1993 Dec;43(5-6):254-61.
2
Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.辛伐他汀对家族性高胆固醇血症患者中带负电荷的低密度脂蛋白亚组分与低密度脂蛋白受体亲和力的影响。
Am J Cardiol. 2004 Feb 15;93(4):414-20. doi: 10.1016/j.amjcard.2003.10.034.
3
Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.辛伐他汀对杂合子家族性高胆固醇血症患者、糖尿病合并混合型高脂蛋白血症患者低密度脂蛋白亚类的影响。
Exp Clin Endocrinol Diabetes. 2002 Jun;110(4):182-7. doi: 10.1055/s-2002-32150.
4
Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.阿托伐他汀和辛伐他汀对家族性高胆固醇血症患者低密度脂蛋白亚组分谱、低密度脂蛋白氧化易感性及氧化型低密度脂蛋白抗体与颈动脉内膜中层厚度关系的影响。
J Investig Med. 2004 Apr;52(3):177-84. doi: 10.1136/jim-52-03-32.
5
Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.辛伐他汀对耐药性家族性高胆固醇血症患者的有益作用。
N Z Med J. 1992 Jul 22;105(938):284-6.
6
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.依折麦布/辛伐他汀对原发性高胆固醇血症患者脂蛋白亚组分的影响:使用两种市售技术对存档样本进行的探索性分析。
Clin Ther. 2007 Nov;29(11):2419-32. doi: 10.1016/j.clinthera.2007.10.004.
7
[Simvastatin in the treatment of familial hypercholesterolemia].辛伐他汀治疗家族性高胆固醇血症
Cas Lek Cesk. 1995 May 17;134(10):310-3.
8
Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.口服避孕药使用者与对照组低密度脂蛋白亚组分谱的差异。
J Clin Endocrinol Metab. 1993 Jan;76(1):197-202. doi: 10.1210/jcem.76.1.8421088.
9
Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.辛伐他汀和环丙贝特单独及联合应用对家族性混合性高脂血症合并冠心病患者血脂谱、血浆纤维蛋白原及低密度脂蛋白颗粒结构和分布的影响
Coron Artery Dis. 1996 Nov;7(11):843-50. doi: 10.1097/00019501-199611000-00009.
10
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.在杂合子家族性高胆固醇血症患者中,低密度脂蛋白亚组分中血小板活化因子乙酰水解酶活性增加,导致氧化过程中溶血磷脂酰胆碱生成增强。
Eur J Clin Invest. 1997 Jul;27(7):595-602. doi: 10.1046/j.1365-2362.1997.1570706.x.

引用本文的文献

1
Familial hypercholesterolaemia.家族性高胆固醇血症
Clin Biochem Rev. 2004 Feb;25(1):49-68.
2
Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.氟伐他汀:其药理学及在高胆固醇血症管理中的应用综述
Drugs. 1996 Mar;51(3):433-59. doi: 10.2165/00003495-199651030-00011.